Barcelona Health Hub, in collaboration with Col·legi de Metges de Barcelona, Esade Ban and Barcelona Activa, are organizing the first e-Health Investment Forum in Barcelona, a meeting point where digital health startups meet investors active in digital health and coming from Spain, Europe and beyond.
This first e-Health Investment Forum edition will be focused on telemedicine solutions. Telemedicine consists of providing health services remotely, through information and communication technology (phone, email, video calls, chats, bots, image exchange, remote monitoring, etc.) and allows monitoring, diagnosing, treating or informing patients and / or professionals.
There will be 2 different categories: Early stage, looking for less than 1 million euros and Growth stage, looking for more than a million euros. A maximum of 10 solutions will be selected to pitch on October 29th.
The winner of each track, growth and pre-seed/seed, will receive $25,000 in Amazon AWS credits to be used across all AWS portfolios. The other finalists will receive $10,000 in AWS credits each. All the pitching companies will benefit from a business mentoring session with Amazon team prior to the event to help them prepare their pitch.
The call for projects is closed, but you can still be part of the e-Health Investment Forum as general public.
Ventures Operations Manager at StartUp Health
Lauren Doolan is the Ventures Operations Manager at StartUp Health, which was founded in 2011 to invest in a global army of entrepreneurs, called Health Transformers, to achieve health moonshots. In her role, Lauren works closely with the Investment Committee to source, review, and select new Health Transformers to invest in and join the StartUp Health portfolio. Additionally, Lauren manages the StartUp Health fellowship program. Prior to joining the StartUp Health team in 2014, Lauren was an Account Executive at Yelp. Lauren graduated from the University of California, Santa Barbara, with a BA in Communications and English. A California native, Lauren now resides in the Bay Area after five years in New York City.
Associate at Heal Capital
Javier Núñez-Vicandi is an Associate at Heal Capital. Before this, he was an Analyst at the New Businesses Fund at M Ventures where he worked on data-driven healthcare, biotechnology and automation investments. Prior to this he was a practicing clinical doctor at Oxford University Hospital Trust with experience in Acute General Medicine/Surgery, Endocrinology, Transplant, Spinal Rehabilitation Medicine and General Practice. He has held posts at the UKs National Spinal Injury Centre and Oxford’s Churchill Hospital Transplant Department, the largest pancreatic transplant centre in Europe. He also acted as an external business consultant at the Wellcome Sanger Institute. Javier holds an MPhil (distinction) from Cambridge University and completed his Bachelor of Medicine, Bachelor of Surgery (MBBS) at Newcastle University
Director Health Entrepreneurship Program at CoMB
Nadia Pons is a biologist, specialized in Innovation and creation of science-based start-ups with more than 8 years of experience in the R+D sector. Founder of the E-Health Investment Forum Barcelona. Currently, she’s leading the Health Entrepreneurship Program at CoMB. Her scientific experience includes different laboratories within the private and public areas, performing diagnostic and research. From 2014 to 2019 she was part of the Business & Innovation office at ICN2, performing a strategic role for science commercialization.
President at Barcelona Health Hub
Cristian Pascual is President of Barcelona Health Hub, a non-profit private organization created to promote innovation in digital health and its transfer to the sector, linking startups, health organizations, companies and investors. He is an industrial engineer and MBA from Esade and the Carlson School of Management. For 19 years he held various management positions in large companies before founding Mediktor, the most accurate AI-based medical assistant for triage, prediagnosis and decision-making support, in 2014. In addition, for 12 years he has been a business angel and currently participates in more than 15 startups.
Partner at Amadeus Capital Partners
Edward Kliphuis is a partner at Amadeus, focussed on later stage European deeptech companies. Prior to joining Amadeus, Edward was at M Ventures, the €400m AUM corporate VC-arm of Merck KGaA, where he was responsible for health-tech, frontier-tech and sustainability investments. Edward led, among others, the investments in Akili Interactive Labs (the first-ever FDA-approved prescription video-game); Wiliot (battery-free Bluetooth tags with infinite lifetime, enabling a true connected-everything), and Sonde Health (voice-analysis platform for health and wellness inferences for use on self-owned devices). Edward is still active as Venture Advisor to M Ventures. Prior to M Ventures, Edward was in the Life Sciences securities team at Kempen & Co, a pan-European merchant bank, covering listed small- and mid-cap Life Sciences equities. He started his career as an analyst within the biopharma investment team of M Ventures. Edward holds an MSc in Biopharmaceutical Sciences from Leiden University, the Netherlands, with a specialisation in pharmacology.
Director at Esade Ban
Fernando Zallo is the Director of ESADE BAN (ESADE Business Angels Network). As VP of “Club de Emprendedores e Inversores ESADE ALUMNI “ he has been coordinating the investors network since 2007. Entrepreneur and consultant, involved mainly in entrepeneurship projects. He holds a degree and MBA in Business Administration (ESADE), as well a a degree in Business Administration of the Universidad Ramón Llull.
S2B Health&Care Manager at Ship2B
Adrià Escolà, MSc in Biomedical Engineering by Universitat Politècnica de Barcelona (BarcelonaTech UPC) and Universitat de Barcelona (UB), is S2B Health&Care Manager. Before joining Ship2B, Adrià was part of the Life Sciences Investment team at Caixa Capital Risc, one of the main Spanish VCs. Nowadays, as S2B Health&Care Manager, he is leading health and quality of life areas, as well as the investment readiness processes. Adrià is also an external reviewer and mentor in many funding programs and accelerators.
Ventures Analyst at Plug and Play
Leonor Alarcón is Ventures Analyst at Plug and Play Spain. She helps big corporations in Spain and France to find the right startups that fulfill their innovation strategies and solve their pain points. Her ultimate goal is to push a startup’s business development plan while helping big corporations pursue their tech transformation. Moreover, she is constantly looking for industry-agnostic investment opportunities to add them into the Plug and Play portfolio, one of the most active early-stage investors worldwide. Also, she is thrilled to see how Covid has accelerated the changing pace of industries, especially in healthcare and education.
Partner at Philips Ventures
Lara Koole is Head of Philips’ venture capital activities in Europe and a founding member of the Philips Ventures team. Experienced in investment banking, start-up fundraising and corporate venturing advisory before joining Philips to build the venture capital group. She is a Dutch-national, based in the Netherlands, and holds a Master-degree in International Financial Economics at the University of Amsterdam. Lara is looking for driven entrepreneurs that are passionate and capable to address (part of) the quadruple aim in healthcare, improving outcomes and lowering costs while increasing patient and staff satisfaction. She is passionate about technology, strategic investing and working together with great teams to scale their companies bringing strategic and industry expertise of Philips to the table. Currently Lara is board director of the Philips Health Technology Venture Fund portfolio companies’ LeQuest, DEARhealth, LindaCare and Sweetch.
Founding Partner at Alta Life Sciences
Miguel Valls is Founding General Partner at Alta Life Sciences. He is an established serial entrepreneur and investor in Spain and Silicon Valley and a former investment banker with several successful investments in life Sciences and Deep Tech companies. Miguel was the co-Founder and CEO of Dadata Capital. Miguel has been the co-founder, investor and advisor to companies like Genotesta, Clear Labs, Genolyte, Spirit Films and Nektria. Miguel is also the co-founder and co-chair of the San Francisco-Barcelona Sister City Committee and Technology Advisor to the Barcelona and Spain Chambers of Commerce. He created the International Technology Forum in 2007, the first program to bring Silicon Valley investors to Spain.
Business Services Director at Barcelona Activa
Jaume Baró i Torres is an experienced manager and mentor with a proven track record in creating and managing business & startup products, programmes and services in Barcelona's ecosystem since 2003. Expertise in Entrepreneurship and Business Needs Analysis. Strong people skills which have allowed to lead different teams to implement successful systems to answer the entrepreneurs & companies needs.
Vice President at Silicon Valley Bank
Flavia Richardson is Vice President, Early Stage Practice UK for Silicon Valley Bank. In her role Flavia manages a portfolio of early-stage and growth technology companies. She has over 8 years’ experience of successfully investing, with a track record in portfolio management and end-to-end transaction management, including due diligence, valuation and structuring of deals.
Associate at Optum Ventures
Prior to joining Optum Ventures, James Lighton began his career at Polar Capital, where he worked as an investor in public equity markets across Europe. Subsequently, he led the inorganic growth strategy at Cera Care - a UK-based home care startup. He graduated from the University of Oxford with a degree in Philosophy, Politics and Economics, and has passed all levels of the CFA.
Founder at Medstartr
Alex B. Fair, MS - is the Founder and CEO of MedStartr, Managing Member of MedStartr Venture Partners, and Organizer of one of the world’s largest communities focused on healthcare Innovation. He originally trained as a research scientist, first in Physics, then Pathology, publishing original research in cancer and heart disease. In the 90’s he had an idea for a medical expert system that took off so he finished off his last research paper and came into the world of business. MedStartr is his 7th startup and MedStartr Venture Fund II is his third fund. His goal is to help thousands of new ideas transform medicine and has been doing so since 2010.
Senior Business Development Manager for Startups at Amazon Web Services
Rosario Muñoz is Senior Business Development for startups at Amazon Web Services (AWS), helping startups accelerate and scale up. Prior to AWS, Rosario was the Chief Operating Officer at Chicfy, a fashion startup, and before that she led the Latin America expansion of Brainly, an EdTech company, acquiring 25 Million users in 2 years. Rosario has spent over 10 years in the Digital native ecosystem, having worked in large corporations such as Facebook and ORACLE. Rosario holds an EMBA by IESE.
Director at INKEF Capital
Thijs Cohen Tervaert is a Director at INKEF. Thijs currently also serves on the board of ViCentra, Aidence, Audion Therapeutics, Rainier Therapeutics and Castor. Prior to INKEF, Thijs was a strategy consultant at the Boston Consulting Group with a focus on health care and technology. He worked on projects for pharmaceutical companies, hospitals and insurers. During a one year secondment, Thijs helped to establish the Amsterdam Health and Technology Institute in 2014. Thijs is a medical doctor and graduated at Leiden University. He has also co-authored several scientific papers.
Managing Partner & Co-Founder at Encomenda Smart Capital
Oriol Juncosa is Managing Partner and Co-Founder of Encomenda Smart Capital, one of the largest super angel fund in Southern Europe focused on seed start-ups. Oriol is also a Partner & Co-Founder of White Peak Partners, a leading M&A and fundraising boutique focused on digital companies with offices in the UK and in Spain. Formerly, he was CFO and advisor to Carto, the leading SaaS intelligence location company based in New York and in Madrid. He helped to scale the company from 10 to over 100 employees and raise over to $25m from Accel Partners and Earlybird. Prior to Carto, he was Investment Director at Nauta Capital, a VC fund with over $300m in AUM. At Nauta he handled technology start-ups like SocialPoint, ABA English and ForceManager. Prior to Nauta Capital, Oriol worked in investment banking and principal investment at Merrill Lynch and BNP Paribas in London for 8 years and in technology strategy consulting with Monitor Group.
Co-Founder & General Manager at SeedLink
Tim Juergens is senior leader with passion for innovation and value creation in health and care. His main focus is on digital health and therapeutics solutions, and he´s a true believer into value-based health care. Tim has 20+ years of international pharma and diagnostics experience, covering commercial, market access, solution development and general management roles in several European countries as well as globally.
Managing Partner at Crista Galli Ventures
Dr. Fiona Pathiraja is Managing Partner at Crista Galli Ventures, a healthtech fund investing in pan-European healthtech. The fund is based in London and Copenhagen and backs founders at Seed and Series A. Prior to investing, Fiona was a Radiologist in the NHS, based at University College London Hospital. She has also worked at the UK Department of Health as clinical advisor to Sir Bruce Keogh, NHS Medical Director. Fiona is dual board certified in Radiology and Public Health and holds an MBA from London Business School and an MPH from the London School of Hygiene and Tropical Medicine.
Associate at Optum Ventures
Prior to joining Optum Ventures, Sam Milliken-Smith worked across the National Health Service (NHS) on strategic and operational projects with The PSC (formerly 2020 Delivery), one of the UK’s leading public service consultancies. Sam graduated from Cambridge University with a Master’s in Bioscience Enterprise and holds a first-class undergraduate degree from Oxford University.
EMEA Lead Healthcare and Life Sciences Startups at Amazon Web Services
Guy Spigelman is the EMEA lead for Healthcare and Life Sciences Startups at Amazon Web Services (AWS). In this role Guy harnesses the technology and people at Amazon to work alongside the investors and founders of startups to accelerate their scientific, engineering and commercial development. Prior to AWS, Guy was VP Portfolio Success at aMoon, Israel's largest health-technology VC and before that he led a network of accelerators supporting over 100 startups per year. Guy has been part of the leadership team of several early-stage startups, including XMPie sold to Xerox and AposTherapy where Guy launched global operations.
Media Director at StartUp Health
As the media director at StartUp Health, Logan Plaster is responsible for broadcasting stories of progress from across the StartUp Health ecosystem. He’s worked one-on-one with hundreds of Health Transformers to craft narratives of impact for every vertical from social media to video to podcast to the written word. Logan is the founding editor in chief of StartUp Health Magazine, which was recognized in 2019 with a Power Press Award for excellence in reporting. Logan is a journalist and creative director with 15 years of experience covering healthcare, technology, entrepreneurship, global health and emergency medicine. After studying at Northwestern’s Medill School of Journalism, Logan worked as the editor of a medical journal for more than a decade. Logan hosted the podcast Health Innovation Matters and is frequently interviewed as a subject matter expert in digital health trends and content strategy. Logan currently lives in downtown Baltimore with his wife and two small children.
Senior Associate at Wellington Partners
Arturo is Senior Associate at Wellington Partners Life Science, one of the leading European Venture Capital firms investing in early and growth stage life science companies. With more than EUR 400 million committed to Life Sciences activities, Wellington has actively supported more than 40 innovative life science companies in the fields of biotechnology, therapeutics, medical technology, diagnostics and digital health. In the digital space, Wellington is supporting early growth companies that positively impact healthcare (therapeutics, diagnostics and services) with an initial ticket size of EUR 5-10M and up to EUR 20M during the lifetime of the company.
Managing Partner at Karista
Catherine Boule's career began at Institut Curie as molecular biology researcher. She then joined Ile de France Innovation where she assisted several Biotech and MedTech companies in their development. Joining Karista in 2003, Catherine is the Managing Partner in charge of the Healthcare portfolio. She is involved in the overall management of the firm, particularly involved in fundraising activities and investors relations. Catherine is investing in Healthcare and Digital Health ventures. She represents Karista at the board of several portfolio companies such as Acticor Biotech, Eyevensys and Incepto. She was also part of the board of Echosens (acquired by Furui Group), Erytech Pharma (listed on Nasdaq: ERYP), Nanobiotix (Listed on Euronext: NANO) and many other successful companies. Catherine holds a MSc in Molecular Biology from University Pierre and Marie Curie and graduated in Innovation Management from AgroParis Tech.
Partner at Kurma Partners
Benjamin is a Partner at Kurma Partners. He invests in early-stage European companies specialized in the development of disruptive molecular diagnostic tools, smart and connected devices, artificial intelligence and digital therapeutics. Prior to joining Kurma Partners, Benjamin was the Head of Digital Health Investments at Zuellig Pharma, one of the largest healthcare solutions groups in Asia. He also worked in Pharma and in Consulting. He holds a MBA from INSEAD Passionate about Healthcare, he is also geeky about music and emotional about football.
Co-founding Partner at PHS Capital
Stephen Seuntjens is a co-founding partner at PHS Capital (Personal Health Solutions), a Amsterdam based venture firm investing in early & mid-stage businesses within digital health. PHS invests in and supports exceptional entrepreneurs with unique digital health propositions that are science based, fulfill individual needs, link surrounding eco-systems of stakeholders and develop into leading global companies. He has over 20 years of global experience in building and developing new businesses, both organically & M&A (buy & sell). He has worked and lived in Minneapolis, Tel Aviv, London and Amsterdam. Companies he has supported include Mind CTI, and Israeli-based, Nasdaq-listed software billing provider; Shapeways, as US based portal company allowing creatives to realize their objects through 3D printing & Directlife, part of Royal Philips Electronics, motivating individuals to become more physically active. Current board member of SkinVision, Pacifica Labs, & Machtfit. Prior to PHS, Stephen Seuntjens was CEO of Philips Lifestyle Incubator, investing in service and product concepts within the wellbeing / consumer health domain.
Founder at Muster Ventures
Adriana Freitas has over 20 years of experience in the telecom market in different networks. She worked inside Telefonica for more than a decade managing international projects at Rio, Miami, NYC, SF and Barcelona. Co-Lead and Exited a Startup in the Business Intelligence area. Adriana is an active member of the Barcelona entrepreneurial community as a mentor, board advisor, and investor. She is founder of the VC consultancy firm Muster.vc.